Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ovarian Small Cell Carcinoma"'
Autor:
Lin DI; Beth Israel Deaconess Medical Center, Department of Pathology, Boston, MA, United States. Electronic address: dilin@bidmc.harvard.edu., Chudnovsky Y; Foundation Medicine Inc., Cambridge, MA, United States., Duggan B; South Coast Gynecologic Oncology, Inc., San Diego, CA, United States., Zajchowski D; The Clearity Foundation, San Diego, CA, United States., Greenbowe J; Foundation Medicine Inc., Cambridge, MA, United States., Ross JS; Foundation Medicine Inc., Cambridge, MA, United States; Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, NY, United States., Gay LM; Foundation Medicine Inc., Cambridge, MA, United States., Ali SM; Foundation Medicine Inc., Cambridge, MA, United States., Elvin JA; Foundation Medicine Inc., Cambridge, MA, United States. Electronic address: jelvin@foundationmedicine.com.
Publikováno v:
Gynecologic oncology [Gynecol Oncol] 2017 Dec; Vol. 147 (3), pp. 626-633. Date of Electronic Publication: 2017 Nov 06.
Autor:
Lavrut PM; 1 Department of Pathology, Hôpital Femme Mère Enfant, CHU de Lyon, France., Le Loarer F; 2 Department of Biopathology, Centre Léon Bérard, Lyon, France.; 3 Université Claude Bernard Lyon, Lyon, France.; 4 Cancer Research Center of Lyon, INSERM U1052, Lyon, France., Normand C; 5 Department of Pediatric Oncology, Centre Léon Bérard, Lyon, France., Grosos C; 6 Department of Surgery, Hôpital Femme Mère Enfant, CHU de Lyon, France., Dubois R; 6 Department of Surgery, Hôpital Femme Mère Enfant, CHU de Lyon, France., Buenerd A; 1 Department of Pathology, Hôpital Femme Mère Enfant, CHU de Lyon, France., Conter C; 5 Department of Pediatric Oncology, Centre Léon Bérard, Lyon, France., Dijoud F; 1 Department of Pathology, Hôpital Femme Mère Enfant, CHU de Lyon, France.; 3 Université Claude Bernard Lyon, Lyon, France., Blay JY; 3 Université Claude Bernard Lyon, Lyon, France.; 4 Cancer Research Center of Lyon, INSERM U1052, Lyon, France.; 7 Department of Oncology, Centre Leon Bérard, Lyon, France., Collardeau-Frachon S; 1 Department of Pathology, Hôpital Femme Mère Enfant, CHU de Lyon, France.; 3 Université Claude Bernard Lyon, Lyon, France.
Publikováno v:
Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society [Pediatr Dev Pathol] 2016 Jan-Feb; Vol. 19 (1), pp. 56-60. Date of Electronic Publication: 2015 Jul 31.
Autor:
Audrey LeFormal, Sebastien Gouy, Félix Blanc-Durand, Ariane Dunant, E. Bentivegna, Alexandra Leary, A Maulard, Mojgan Devouassoux-Shisheboran, Aurélie Auguste, Jean-Yves Scoazec, Patricia Pautier, Philippe Morice, Catherine Genestie
Publikováno v:
British Journal of Cancer
Background Ovarian small cell carcinoma, hypercalcaemic type (SCCOHT) is a rare and lethal disease affecting young women. As histological diagnosis is challenging and urgent, there is a clear need for a robust diagnostic test. While mutations in the
Autor:
Gerlinde Averous, Gaëtan MacGrogan, Jean-Michel Coindre, Sabrina Croce, Laurent Arnould, Frédéric Guyon, Cécile Le Naoures-Méar, Michel Longy, Marie Karanian-Philippe, Valérie Velasco, Anne Floquet
Publikováno v:
American Journal of Surgical Pathology. 39:1197-1205
Ovarian small cell carcinoma of the hypercalcemic type (SCCOHT)/ovarian rhabdoid tumor is a rare and highly malignant tumor that typically occurs in young women. Up until now the diagnosis has been made on the basis of morphology without any specific
Autor:
Douglas I. Lin, Yakov Chudnovsky, Bridget Duggan, Deborah Zajchowski, Joel Greenbowe, Jeffrey S. Ross, Laurie M. Gay, Siraj M. Ali, Julia A. Elvin
Publikováno v:
Gynecologic oncology. 147(3)
Small cell carcinoma of the ovary, hypercalcemic-type (SCCOHT) is a rare, extremely aggressive neoplasm that usually occurs in young women and is characterized by deleterious germline or somatic SMARCA4 mutations. We performed comprehensive genomic p
Autor:
Iwona K. Rzepecka, Beata Spiewankiewicz, Agnieszka Podgorska, Joanna Plisiecka-Halasa, Agnieszka Dansonka-Mieszkowska, Alina Rembiszewska, Agnieszka Budzilowska, Bozena Konopka, Joanna Moes-Sosnowska, Jolanta Kupryjanczyk, Lukasz Szafron, W Grajkowska
Publikováno v:
Polish Journal of Pathology. 4:238-246
Ovarian tumors from two patients, compatible by histological and immunohistochemical criteria with small cell carcinoma of hypercalcemic type (SCCHT) (WT1+, EMA dispersed+, synaptophysin+ or dispersed+), were extensively sampled in order to find clue
Autor:
Arndt Hartmann, Engelbert Heimerl, David L. Wachter, Matthias W. Beckmann, Johanna D Strehl, Jutta Fiedler, Abbas Agaimy
Publikováno v:
Annals of diagnostic pathology. 19(4)
The role of the switch/sucrose nonfermenting chromatin remodeling complex in the initiation and progression of cancer is emerging. In the female genital tract, only ovarian small cell carcinoma, hypercalcemic type harbors recurrent inactivating SMARC
Autor:
Dorota Nowakowska, Agnieszka Dansonka-Mieszkowska, Jolanta Kupryjanczyk, Agnieszka Budzilowska, Bozena Konopka, Lukasz Szafron, Joanna Moes-Sosnowska, Agnieszka Podgorska, Joanna Plisiecka-Halasa, Iwona K. Rzepecka
Publikováno v:
Orphanet Journal of Rare Diseases
Background SMARCA4 mutations have recently been identified as driving lesions of the ovarian small cell carcinoma of hypercalcemic type (SCCHT). Familial occurrence of this neoplasm was described previously. Methods We looked for germline SMARCA4 alt